# Serina Therapeutics, Inc.: Form 8-K, filed Dec 1, 2023

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: 8-K
- Filed: 2023-12-01
- Accepted by EDGAR: Dec 1, 2023, 16:05 ET
- Period: 2023-11-27
- Accession: 0001493152-23-043393
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000149315223043393/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000149315223043393/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000149315223043393/form8-k.htm

Filed Dec 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-043393. Last ingested by Listed: Nov 13, 2026, 15:52 ET. No prices; not investment advice.
